How much does tirzepatide cost on Scripts?

Once inside the Scripts portal, ask for tirzepatide pricing as its own itemized line, not bundled into a general GLP-1 rate. Confirm per-vial cost across the dose ladder you prescribe, since tirzepatide also titrates and different doses can mean different vial sizes or concentrations. Confirm whether multi-month or larger vials change per-dose economics, and whether your rate is fixed across refill cycles or subject to renegotiation. If you offer both semaglutide and tirzepatide, get both rates side by side so you can see which drug carries better margin at your patient prices.

This matters because patient demand shifts between the two molecules over time. If your cohort migrates toward tirzepatide, a rate you confirmed only on semaglutide leaves your fastest-growing line undefined. Pricing each GLP-1 SKU independently inside the portal keeps your margin model accurate as the mix changes.

Fizy Health shows resolved per-vial 503A cost for tirzepatide on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment — the same model it uses for semaglutide and every other SKU. Because each molecule and strength shows its own cost, you can compare tirzepatide and semaglutide economics directly and set patient pricing on numbers you can read before the consult, without completing Apply & Verify first.

That makes a two-drug GLP-1 program easier to run. You can model margin on each molecule across its titration ladder, see how the mix affects your blended margin, and adjust patient pricing as demand shifts. Compare a visible tirzepatide per-vial cost against any Scripts portal rate on the same strength and vial size to confirm which model gives you clearer SKU-level economics.